Particular nations contain a "substantially related" capture-all clause within their drug legislation, such as New Zealand and Australia. This includes six-APB as it is comparable in chemical composition to The category A drug MDA, that means six-APB might be considered for a managed material analogue in these jurisdictions.[19]Discriminative stimu